Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis

Journal of Diabetes Research - Tập 2017 - Trang 1-8 - 2017
Fanqiang Meng1, Li Song1, Wenyue Wang1
1Department of Gastrointestinal Surgery, China-Japan Friendship Hospital, Beijing 100029, China

Tóm tắt

Introduction. Diabetic population has a higher risk of colorectal cancer (CRC) incidence and mortality than nondiabetics. The role of metformin in CRC prognosis is still controversial. The meta-analysis aims to investigate whether metformin improves the survival of diabetic CRC patients.Methods. PubMed, EMBASE, and Cochrane Library were searched till July 1, 2016. Cohort studies were included. All articles were evaluated by Newcastle-Ottawa Scale. Hazard Ratios (HRs) with 95% confidence intervals (CIs) for each study were calculated and pooled HRs with corresponding 95% CIs were generated using the random-effects model. Heterogeneity and publication bias were assessed.Results. We included seven cohort studies with a medium heterogeneity (I2= 56.1% andp=0.033) in our meta-analysis. An improved overall survival (OS) for metformin users over nonusers among colorectal cancers with diabetes was noted (HR 0.75; 95% CI 0.65 to 0.87). However, metformin reveals no benefits for cancer-specific survival (HR 0.79, 95%, CI 0.58 to 1.08).Conclusions. Metformin prolongs the OS of diabetic CRC patients, but it does not affect the CRC-specific survival. Metformin may be a good choice in treating CRC patients with diabetes mellitus in clinical settings.

Từ khóa


Tài liệu tham khảo

2014

10.3945/ajcn.115.127092

10.1007/s10151-016-1498-3

10.1371/journal.pone.0143596

10.1007/s00432-010-0879-7

10.1002/cncr.26420

10.1007/s00125-012-2555-8

10.1016/j.clinre.2015.05.021

10.1097/dcr.0b013e3182a479f9

10.1172/jci200113505

10.1002/cncr.21950

2001, Journal of Nutrition, 131, supplement 11, 3109S

2007, American Journal of Clinical Nutrition, 86, s867, 10.1093/ajcn/86.3.867S

10.1002/ijc.26421

10.1158/1055-9965.EPI-13-0347

10.3747/co.23.2809

10.1016/j.canep.2013.04.015

10.1038/bjc.2015.259

10.1002/ijc.29720

10.1245/s10434-015-5028-8

10.1038/bjc.2012.71

10.1007/s10654-010-9491-z

10.1016/j.ijsu.2010.02.007

10.3748/wjg.v21.i19.6026

10.1080/13880209.2016.1176057

10.1097/md.0000000000002749

10.18632/oncotarget.387

10.1007/s13277-016-4945-x

10.1016/j.clcc.2016.04.011

2014, PLoS ONE, 9

10.2174/157016110791112359

Thông tin
Thông tin xuất bản

Journal of Diabetes Research

Tập 2017

1-8

Thông tin tác giả